Currently, India imposes a 10 per cent tariff on pharmaceutical imports from the US, while the US does not levy any tariff on ...

Global brokerage firm Citi said on Tuesday there is a low likelihood of the US imposing tariffs on Indian pharmaceuticals, ...

Royal Bank of Canada has hired longtime Citigroup Inc. dealmaker Rob Jurd as its head of industrial investment banking in ...

The rally, fulled by fears of escalating inflation and a potential slowdown in global economic growth, has drawn sharp ...

Volatility from trade tensions with the US kept a lid on Canada’s market for equity deals in the first quarter, even as ...

TICKETS for Lady Gaga’s highly anticipated Mayhem Ball tour are now on sale – and they’re expensive. Last week the US ...

Citigroup's strong CET1 and PCR metrics indicate financial stability and resilience compared to competitors. Read why I think ...

As the first quarter ends, strategists are worried about more than just Donald Trump's tariffs as the outlook for stocks has ...

Citi's analysis indicates that companies with lower exposure to US generics, including Torrent Pharma, Sun Pharma, and Divi's ...

Citi believes that Pharma companies will aim to pass on the tariff hikes to payors. In case the costs are not passed on to ...